News & Events

• March 10, 2022
  

  C-Path and Tufts Medical Center Collaborate on EHR Data Transfer

  The endeavor represents a major milestone for C-Path   TUCSON, Ariz., March 10, 2022 — Critical Path Institute (C-Path) and Tufts Medical Center have announced a collaboration to transfer electronic healthcare records (EHR) data to C-Path as part of the real-world data (RWD) effort to generate actionable real-world evidence (RWE) for neonatal drug development. This...
• December 1, 2021
  

  C-Path and NICHD to Share Real-world Data to Advance Neonatal Drug Development

  International Neonatal Consortium (INC) today announced a seminal data-sharing collaboration with the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health, as a part of a U.S. Food and Drug Administration (FDA) sponsored project to generate actionable real-world evidence (RWE) for neonatal drug development, from real-world neonate data (RWD).

• September 16, 2021
  

  C-Path Appoints Tufts’ Jonathan M. Davis as Senior Advisor in Pediatrics

  C-Path today announced the appointment of Jonathan M. Davis, M.D., as Senior Advisor in Pediatrics working with its International Neonatal Consortium (INC) and advising on drug and device development in infants and children, effective immediately.

• May 12, 2021
  

  C-Path Announces Accelerated Data Sharing Collaboration with Tufts Medical Center

  FDA Grant Supports Use of Real-World Data to Generate Real-World Evidence in Neonates

  TUCSON, Ariz., May 12, 2021 — Critical Path Institute (C-Path) and Tufts Medical Center have announced a joint venture to integrate the first patient-level clinical trial data to generate actionable real-world evidence (RWE) for neonatal drug development, from real-world neonate data (RWD). This activity, funded by a grant from the U.S. Food and Drug Administration (FDA), is being executed through a neonatal pilot project within C-Path’s International Neonatal Consortium (INC). The data sharing collaboration and transfer also marks the fastest on record for C-Path — starting with the Data Contribution Agreement negotiations and receipt of the data in three months’ time this March.

• October 27, 2020
  

  FDA Awards C-Path Grant to Use Real-World Data to Generate Real-World Evidence in Neonates

  Pilot project will include the development of a Real-World Data and Analytics Platform TUCSON, Ariz., October 27, 2020 — Arizona-based Critical Path Institute (C-Path) is pleased to announce it has been awarded a multi-year grant by the U.S. Food and Drug Administration (FDA) to advance standards and methodologies designed to generate real-world evidence (RWE) from...